Is a complete ETR/2X1 research report available?

No complete published report is available for etr/2X1 (ETR/2X1) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/2X1 (ETR/2X1)

Deutsche Börse Xetra: ETR/2X1 · EUR

€111

-2.40 (-2.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/2X1 analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	9.7B
Revenue (ttm)	4.9M
Net income (ttm)	-332.2M
EPS (ttm)	-€4.52
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.9M
Net income (ttm): -332.2M
EPS (ttm): -€4.52
Market cap: 9.7B

All ETR/2X1 indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

EUR

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	DE
Employees	80
Employees Change	5%
Employees Change Percent	8.06
Enterprise value	EUR 9.3B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-28
Market cap	EUR 9.7B
Price	EUR 111
Price currency	EUR
Rev Per Employee	61,500x
Sic	2836
Symbol	etr/2X1
Website	https://www.abivax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.42%
FCF yield	-1.84%
P/B ratio	22.63x
P/S ratio	1,976.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 4.9M
Gross Profit Growth	-59.82%
Gross Profit Growth Q	35.21%
Gross Profit Growth3 Y	3.13%
Net Income	EUR -332.2M
Pretax Margin	-6,628.54%
Profit Per Employee	EUR -4.2M
ROA	-44.65
Roa5y	-37.56
ROCE	-52.6
ROE	-157.1
Roe5y	-198.1
ROIC	-56.56

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	-59.82x
Revenue Growth Q	35.21x
Revenue Growth3 Y	3.13x
Revenue Growth5 Y	222.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 547.1M
Cash	EUR 491.6M
Current Assets	EUR 513.2M
Current Liabilities	EUR 62.2M
Debt	EUR 34.2M
Debt Equity	EUR 0.08
Debt FCF	EUR -0.19
Equity	EUR 429.6M
Interest Coverage	-9.63
Liabilities	EUR 117.5M
Long Term Assets	EUR 33.9M
Long Term Liabilities	EUR 55.3M
Net Cash	EUR 457.3M
Net Cash By Market Cap	EUR 4.7
Net Debt Equity	EUR -1.06
Tangible Book Value	EUR 404.6M
Tangible Book Value Per Share	EUR 5.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.25
Net Working Capital	EUR -39.5M
Quick ratio	8.07
Working Capital	EUR 451M
Working Capital Turnover	EUR 0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
200-day SMA	99.63
50-day SMA	102.6
50-day SMA vs 200-day SMA	50over200
All Time High	137.4
All Time High Change	-18.05%
All Time High Date	2026-07-03
All Time Low	60.85
All Time Low Change	85.05%
All Time Low Date	2026-06-03
ATR	4.74
Ch YTD	-6.63
High	111.2
High52	137.4
High52 Date	2026-07-03
High52ch	-19.07%
Low	111.2
Low52	60.85
Low52 Date	2026-06-03
Low52ch	82.74%
Ma50ch	9.77%
Price vs 200-day SMA	13.01%
RSI	51.33
RSI Monthly	0
RSI Weekly	55.35
Sharpe ratio	0.96x
Sortino ratio	1.52
Total Return	-16.25%
Tr YTD	-6.63
Tr1m	31.01%
Tr1w	-5.62%
Tr3m	15.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -255.1M
Operating margin	-5,184.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,953,615%
Net Borrowing	-53,822,000
Shares Insiders	0.58%
Shares Institutions	83.67%
Shares Qo Q	0.96%
Shares Yo Y	16.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -231.8M
Adjusted OCF	-231,688,000
Average Volume	3,463.1x
Bv Per Share	5.42
CAPEX	EUR -152,000
Ch1m	31.01
Ch1w	-5.62
Ch3m	15.25
Ch6m	5.83
Change	-2.11%
Change From Open	0
Close	113.6
Days Gap	-2.11
Depreciation Amortization	1,080,000
Earnings Date	2026-09-21
EBIT	EUR -255.1M
EBITDA	EUR -254M
EPS	EUR -4.52
F Score	3
FCF	EUR -178.5M
FCF EV Yield	-1.93x
Financing CF	555,217,000
Fiscal Year End	December
Founded	2,013
Goodwill	18,419,000
Income Tax	EUR 6.1M
Investing CF	-8,780,000
Is Primary Listing	0
Last Earnings Date	2026-03-23
Last Report Date	2026-03-31
Ma150	102.3
Ma150ch	10.11%
Ma20	118.6
Ma20ch	-5.09%
Net CF	373,847,000
Next Earnings Date	2026-09-21
Open	111.2
Ppne	1,783,000
Price Date	2026-07-27
Ptbv Ratio	24.03
Relative Volume	0.13x
Revenue	4,920,000x
SBC By Revenue	1,083.7x
Share Based Comp	53,318,000
Tax By Revenue	123.5x
Tr6m	5.83%
Volume	0
Z Score	22.21

ETR/2X1 (ETR/2X1)

Coverage state: Market snapshot only — no published research

Generate the first ETR/2X1 analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/2X1

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/2X1 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/2X1

Frequently asked questions